Frameshift mutation S368fs in the gene encoding cytoskeletal β-actin leads to ACTB-associated syndromic thrombocytopenia by impairing actin dynamics

Heterozygous dominant mutations in the ubiquitously produced cytoskeletal β–actin isoform lead to a broad range of human disease phenotypes, which are currently classified as three distinct clinical entities termed Baraitser-Winter–Cerebrofrontofacial syndrome (BWCFF), ACTB–associated pleiotropic ma...

Full description

Bibliographic Details
Main Authors: Johannes N. Greve, Frederic V. Schwäbe, Thomas Pokrant, Jan Faix, Nataliya Di Donato, Manuel H. Taft, Dietmar J. Manstein
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:European Journal of Cell Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S017193352200019X
_version_ 1818217542081052672
author Johannes N. Greve
Frederic V. Schwäbe
Thomas Pokrant
Jan Faix
Nataliya Di Donato
Manuel H. Taft
Dietmar J. Manstein
author_facet Johannes N. Greve
Frederic V. Schwäbe
Thomas Pokrant
Jan Faix
Nataliya Di Donato
Manuel H. Taft
Dietmar J. Manstein
author_sort Johannes N. Greve
collection DOAJ
description Heterozygous dominant mutations in the ubiquitously produced cytoskeletal β–actin isoform lead to a broad range of human disease phenotypes, which are currently classified as three distinct clinical entities termed Baraitser-Winter–Cerebrofrontofacial syndrome (BWCFF), ACTB–associated pleiotropic malformation syndrome with intellectual disability (ACTB–PMSID), and ACTB–associated syndromic thrombocytopenia (ACTB–AST). The latter two are distinguishable from BWCFF by the presence of milder craniofacial features and less pronounced developmental abnormalities, or the absence of craniofacial features in combination with a characteristic thrombocytopenia with platelet anisotropy. Production and correct function of β–actin is required for multiple essential processes in all types of cells. Directed cell migration, cytokinesis and morphogenesis are amongst the functions that are supported by β–actin. Here we report the recombinant production and biochemical characterization of the ACTB–AST mutant p.S368fs, resulting in an altered sequence in the C–terminal region of β–actin that includes a replacement of the last 8 residues and an elongation of the molecule by 4 residues. The mutation affects a region important for actin polymerization and actin–profilin interaction. Accordingly, we measured markedly reduced rates of nucleation and polymerization during spontaneous actin assembly and lower affinity of p.S368fs for human profilin–1. The reduced affinity is also reflected in the lower propensity of profilin–1 to extend the nucleation phase of p.S368fs. While localized in close proximity to actin–cofilin and actin–myosin interfaces, we determined only minor effects of the mutation on the interaction of mutant filaments with cofilin and myosin family members. However, allosteric effects on sites distant from the mutation manifest themselves in a 7.9 °C reduction in thermal denaturation temperature, a 2–fold increase in the observed IC50 for DNase–I, and changes in nucleotide exchange kinetics. Our results support a disease mechanism involving impaired actin dynamics and function through disruption of actin–profilin interactions and further exacerbated by allosteric perturbations.
first_indexed 2024-12-12T07:09:31Z
format Article
id doaj.art-f4cd10b5d3b14de5b63c994899b160c7
institution Directory Open Access Journal
issn 0171-9335
language English
last_indexed 2024-12-12T07:09:31Z
publishDate 2022-04-01
publisher Elsevier
record_format Article
series European Journal of Cell Biology
spelling doaj.art-f4cd10b5d3b14de5b63c994899b160c72022-12-22T00:33:39ZengElsevierEuropean Journal of Cell Biology0171-93352022-04-011012151216Frameshift mutation S368fs in the gene encoding cytoskeletal β-actin leads to ACTB-associated syndromic thrombocytopenia by impairing actin dynamicsJohannes N. Greve0Frederic V. Schwäbe1Thomas Pokrant2Jan Faix3Nataliya Di Donato4Manuel H. Taft5Dietmar J. Manstein6Institute for Biophysical Chemistry and Structural Biochemistry, Medizinische Hochschule Hannover, Hannover 30625, GermanyInstitute for Biophysical Chemistry and Structural Biochemistry, Medizinische Hochschule Hannover, Hannover 30625, GermanyInstitute for Biophysical Chemistry and Structural Biochemistry, Medizinische Hochschule Hannover, Hannover 30625, GermanyInstitute for Biophysical Chemistry and Structural Biochemistry, Medizinische Hochschule Hannover, Hannover 30625, GermanyInstitute for Clinical Genetics, University Hospital, TU Dresden, Dresden 01307, GermanyInstitute for Biophysical Chemistry and Structural Biochemistry, Medizinische Hochschule Hannover, Hannover 30625, GermanyInstitute for Biophysical Chemistry and Structural Biochemistry, Medizinische Hochschule Hannover, Hannover 30625, Germany; Division for Structural Biochemistry, Hannover Medical School, Carl Neuberg Str. 1, D–30625 Hannover, Germany; RESiST, Cluster of Excellence 2155, Medizinische Hochschule Hannover, 30625 Hannover, Germany; Correspondence to: Institute for Biophysical Chemistry, Medizinische Hochschule Hannover, Fritz Hartmann Centre for Medical Research, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.Heterozygous dominant mutations in the ubiquitously produced cytoskeletal β–actin isoform lead to a broad range of human disease phenotypes, which are currently classified as three distinct clinical entities termed Baraitser-Winter–Cerebrofrontofacial syndrome (BWCFF), ACTB–associated pleiotropic malformation syndrome with intellectual disability (ACTB–PMSID), and ACTB–associated syndromic thrombocytopenia (ACTB–AST). The latter two are distinguishable from BWCFF by the presence of milder craniofacial features and less pronounced developmental abnormalities, or the absence of craniofacial features in combination with a characteristic thrombocytopenia with platelet anisotropy. Production and correct function of β–actin is required for multiple essential processes in all types of cells. Directed cell migration, cytokinesis and morphogenesis are amongst the functions that are supported by β–actin. Here we report the recombinant production and biochemical characterization of the ACTB–AST mutant p.S368fs, resulting in an altered sequence in the C–terminal region of β–actin that includes a replacement of the last 8 residues and an elongation of the molecule by 4 residues. The mutation affects a region important for actin polymerization and actin–profilin interaction. Accordingly, we measured markedly reduced rates of nucleation and polymerization during spontaneous actin assembly and lower affinity of p.S368fs for human profilin–1. The reduced affinity is also reflected in the lower propensity of profilin–1 to extend the nucleation phase of p.S368fs. While localized in close proximity to actin–cofilin and actin–myosin interfaces, we determined only minor effects of the mutation on the interaction of mutant filaments with cofilin and myosin family members. However, allosteric effects on sites distant from the mutation manifest themselves in a 7.9 °C reduction in thermal denaturation temperature, a 2–fold increase in the observed IC50 for DNase–I, and changes in nucleotide exchange kinetics. Our results support a disease mechanism involving impaired actin dynamics and function through disruption of actin–profilin interactions and further exacerbated by allosteric perturbations.http://www.sciencedirect.com/science/article/pii/S017193352200019XActinopathyAllosteryCofilinCytoskeletonMyosinProfilin
spellingShingle Johannes N. Greve
Frederic V. Schwäbe
Thomas Pokrant
Jan Faix
Nataliya Di Donato
Manuel H. Taft
Dietmar J. Manstein
Frameshift mutation S368fs in the gene encoding cytoskeletal β-actin leads to ACTB-associated syndromic thrombocytopenia by impairing actin dynamics
European Journal of Cell Biology
Actinopathy
Allostery
Cofilin
Cytoskeleton
Myosin
Profilin
title Frameshift mutation S368fs in the gene encoding cytoskeletal β-actin leads to ACTB-associated syndromic thrombocytopenia by impairing actin dynamics
title_full Frameshift mutation S368fs in the gene encoding cytoskeletal β-actin leads to ACTB-associated syndromic thrombocytopenia by impairing actin dynamics
title_fullStr Frameshift mutation S368fs in the gene encoding cytoskeletal β-actin leads to ACTB-associated syndromic thrombocytopenia by impairing actin dynamics
title_full_unstemmed Frameshift mutation S368fs in the gene encoding cytoskeletal β-actin leads to ACTB-associated syndromic thrombocytopenia by impairing actin dynamics
title_short Frameshift mutation S368fs in the gene encoding cytoskeletal β-actin leads to ACTB-associated syndromic thrombocytopenia by impairing actin dynamics
title_sort frameshift mutation s368fs in the gene encoding cytoskeletal β actin leads to actb associated syndromic thrombocytopenia by impairing actin dynamics
topic Actinopathy
Allostery
Cofilin
Cytoskeleton
Myosin
Profilin
url http://www.sciencedirect.com/science/article/pii/S017193352200019X
work_keys_str_mv AT johannesngreve frameshiftmutations368fsinthegeneencodingcytoskeletalbactinleadstoactbassociatedsyndromicthrombocytopeniabyimpairingactindynamics
AT fredericvschwabe frameshiftmutations368fsinthegeneencodingcytoskeletalbactinleadstoactbassociatedsyndromicthrombocytopeniabyimpairingactindynamics
AT thomaspokrant frameshiftmutations368fsinthegeneencodingcytoskeletalbactinleadstoactbassociatedsyndromicthrombocytopeniabyimpairingactindynamics
AT janfaix frameshiftmutations368fsinthegeneencodingcytoskeletalbactinleadstoactbassociatedsyndromicthrombocytopeniabyimpairingactindynamics
AT nataliyadidonato frameshiftmutations368fsinthegeneencodingcytoskeletalbactinleadstoactbassociatedsyndromicthrombocytopeniabyimpairingactindynamics
AT manuelhtaft frameshiftmutations368fsinthegeneencodingcytoskeletalbactinleadstoactbassociatedsyndromicthrombocytopeniabyimpairingactindynamics
AT dietmarjmanstein frameshiftmutations368fsinthegeneencodingcytoskeletalbactinleadstoactbassociatedsyndromicthrombocytopeniabyimpairingactindynamics